One study reported that B cells from melanoma patients' peripheral blood express TNF-α and/or IL-6, and TNF-α transcripts from single B cells extracted from melanoma metastases were associated with reduced responsiveness to checkpoint inhibitor immunotherapy.12 The gene discussed is IL6; the disease is melanoma.